GAPC Antibody

What are the known epitopes of GapC proteins that antibodies typically target?

Several key epitopes of GapC proteins have been identified that serve as targets for antibody development:

• The "TRINDLT" epitope at positions 30-36 of Streptococcus dysgalactiae GapC has been identified as a conserved B-cell epitope. Site-directed mutagenic analysis has demonstrated that residues R31, I32, N33, D34, and L35 form the core of this epitope, representing the minimal determinant recognized by monoclonal antibody 1F2 (mAb1F2) .

• Another important epitope is "TGFFAKK" at positions 97-103 of S. dysgalactiae GapC. Research using monoclonal antibody 1E11 (mAb1E11) to screen a phage-displayed 12-mer random peptide library confirmed that residues G98, F99, F100, and K103 form the core of this B-cell epitope .

• Both of these epitopes show high homology among different streptococcus species, making them valuable targets for cross-reactive antibodies in bacterial research .

How are monoclonal antibodies against GAPC typically generated?

The development of monoclonal antibodies against GAPC typically employs several established techniques:

• Hybridoma technology: This classical approach involves immunizing mice with purified GAPC protein or peptides corresponding to specific epitopes, followed by fusion of B cells with myeloma cells to create immortalized hybridoma cell lines. The search results describe monoclonal antibodies 1E11 (mAb1E11) and 1F2 (mAb1F2) generated against S. dysgalactiae GapC using this technique .

• Phage display screening: This method allows for identification of specific epitopes recognized by antibodies. Researchers have used phage-displayed 12-mer random peptide libraries (Ph.D.-12) to screen for peptides that bind to GAPC antibodies, revealing consensus motifs like "TGFFAKK" and "TRINDLT" that match sequences in the GapC protein .

• Recombinant expression systems: Some approaches utilize recombinant bacteria expressing GAPC epitopes. For example, researchers constructed a recombinant Escherichia coli XL1-Blue strain that displayed GapC₁₋₁₅₀ on its surface by replacing the ompA gene with lpp'-ompA-gapC1₁₋₁₅₀, allowing for immunization with the surface-displayed epitope .

What experimental methods can validate GAPC antibody specificity?

Validating GAPC antibody specificity requires a multi-faceted approach:

• Epitope mapping: Techniques like phage display can identify the specific sequence recognized by an antibody. The search results describe using a phage-displayed 12-mer random peptide library to identify epitopes recognized by monoclonal antibodies against GapC, with most positive clones matching consensus motifs like "TGFFAKK" that correspond to specific amino acid sequences in the GapC protein .

• Site-directed mutagenesis: This approach validates the importance of specific amino acid residues in antibody recognition. Research has shown that modifying core residues within epitopes (e.g., G98, F99, F100, and K103 in the "TGFFAKK" epitope) significantly reduces antibody binding, confirming their critical role in the epitope structure .

• Cross-reactivity testing: Examining antibody binding to GapC proteins from different species helps establish specificity and potential cross-reactivity. The high homology of GapC epitopes among different streptococcus species suggests that antibodies targeting these regions may provide cross-protection .

• Immunoassays: Various methods including indirect enzyme-linked immunosorbent assay (ELISA), fluorescence-activated cell sorting, and laser-scanning confocal microscopy can verify antibody binding to target proteins in different experimental contexts .

How should I design experiments to investigate GAPC protein-protein interactions?

Investigating GAPC protein-protein interactions requires careful experimental design:

• Co-immunoprecipitation (Co-IP) approach:

  • Use GAPC antibodies to pull down protein complexes from cell lysates

  • Analyze co-precipitated proteins by Western blot or mass spectrometry

  • Include appropriate controls (pre-immune serum, irrelevant antibodies)

  • Consider crosslinking to stabilize transient interactions

• Validation of specific interactions:

  • Confirm interactions using reverse Co-IP (using antibodies against the interacting partner)

  • Perform reciprocal pull-downs with tagged versions of proteins

  • Research has confirmed that MeGAPCs physically interact with autophagy-related proteins MeATG8b and MeATG8e, which negatively regulates autophagic activity

• Functional assessment of interactions:

  • Analyze how interactions affect enzymatic activities (e.g., MeATG8b and MeATG8e negatively regulate the activities of NAD-dependent MeGAPDHs)

  • Examine the biological consequences of disrupting these interactions

  • The search results highlight that MeGAPCs-MeATG8 interactions influence plant disease resistance against cassava bacterial blight

• Localization studies:

  • Use immunofluorescence microscopy to assess co-localization

  • Examine subcellular distribution of interacting proteins under different conditions

  • Monitor changes in protein interactions during stress or infection

What controls are essential when using GAPC antibodies in immunoassays?

Proper controls are critical for generating reliable results with GAPC antibodies:

• Positive controls:

  • Purified recombinant GAPC protein at known concentrations

  • Cells/tissues known to express high levels of GAPC

  • Overexpression systems (e.g., transient expression in Nicotiana benthamiana as described in the search results)

• Negative controls:

  • GAPC-silenced samples (using virus-induced gene silencing as described in the research)

  • Irrelevant primary antibody of the same isotype

  • Secondary antibody-only controls to assess non-specific binding

  • Pre-immune serum controls for polyclonal antibodies

• Specificity controls:

  • Peptide competition assays using the immunizing peptide or known epitope

  • Western blot analysis showing a single band at the expected molecular weight

  • Gradual dilution series to establish detection limits

  • Comparison with alternative antibodies targeting different GAPC epitopes

• Experimental validation controls:

  • Ensure consistent sample preparation across experimental groups

  • Include loading controls for Western blots (housekeeping proteins)

  • Standardize incubation times and temperatures

  • Process all samples simultaneously when possible

How can I optimize immunoprecipitation protocols for GAPC antibodies?

Optimizing immunoprecipitation (IP) protocols for GAPC antibodies requires attention to several key parameters:

• Lysis buffer optimization:

  • Use buffers that preserve protein-protein interactions without denaturing epitopes

  • Include appropriate detergents (mild non-ionic detergents like 0.5-1% NP-40 or Triton X-100)

  • Add protease inhibitors to prevent degradation of GAPC and interacting proteins

  • Consider phosphatase inhibitors if studying phosphorylation-dependent interactions

• Antibody selection and concentration:

  • Choose antibodies with high affinity for native GAPC

  • Determine optimal antibody concentration (typically 2-5 μg per 500 μg of total protein)

  • Consider using monoclonal antibodies for higher specificity in complex samples

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Incubation conditions:

  • Optimize temperature and duration for antibody-antigen binding (typically overnight at 4°C)

  • Determine appropriate washing stringency to remove non-specific binding

  • Establish effective elution conditions that release GAPC complexes without contamination

  • Consider crosslinking antibodies to beads to prevent antibody co-elution

• Verification strategies:

  • Confirm successful pull-down by Western blot analysis of input, flow-through, and elution fractions

  • Use known GAPC-interacting proteins as positive controls (e.g., ATG8 proteins)

  • Include IgG control to identify non-specific binding

  • Consider alternative approaches like proximity-dependent biotin identification for validation

What methodologies can identify novel GAPC-interacting proteins?

Several complementary approaches can identify novel GAPC-interacting proteins:

• Immunoprecipitation coupled with mass spectrometry:

  • Pull down GAPC complexes using validated antibodies

  • Analyze co-precipitated proteins by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

  • Compare results with control IPs to filter out non-specific interactions

  • Validate candidates by reciprocal co-IP and functional assays

• Yeast two-hybrid screening:

  • Use GAPC as bait to screen cDNA libraries

  • Test direct binary interactions in a cellular context

  • Follow up with biochemical validation in the original biological system

  • Consider split-ubiquitin systems for membrane-associated interactions

• Proximity-dependent labeling techniques:

  • Express GAPC fused to biotin ligase (BioID) or peroxidase (APEX)

  • Allow enzymatic biotinylation of proteins in close proximity to GAPC

  • Purify biotinylated proteins and identify by mass spectrometry

  • This approach can capture transient or weak interactions missed by co-IP

• Protein array screening:

  • Probe protein arrays with purified GAPC protein

  • Detect binding using antibodies against GAPC

  • Identify candidates and validate with orthogonal methods

  • Consider domain-specific interactions using truncated GAPC constructs

The search results highlight that MeGAPCs physically interact with autophagy-related proteins MeATG8b and MeATG8e, and these interactions are involved in plant disease resistance . Similar approaches could identify additional interaction partners in different biological contexts.

How can GAPC antibodies be used to study the role of GAPC in plant disease resistance?

GAPC antibodies provide powerful tools for investigating GAPC's role in plant immunity:

• Expression analysis during pathogen infection:

  • Monitor GAPC protein levels in response to pathogens using Western blot

  • Compare expression in resistant versus susceptible plant varieties

  • Track temporal changes during disease progression

  • The search results show that MeGAPCs act as negative regulators of plant disease resistance against Xanthomonas axonopodis pv manihotis (Xam)

• Protein interaction dynamics during immune responses:

  • Use co-immunoprecipitation to analyze how pathogen infection affects GAPC interactions with autophagy proteins

  • Research has shown that MeGAPCs physically interact with autophagy-related proteins MeATG8b and MeATG8e

  • Examine how these interactions change during defense responses

  • Analyze how GAPC-ATG interactions affect defense-related autophagy

• Subcellular localization studies:

  • Track GAPC relocalization during immune responses using immunofluorescence

  • Examine co-localization with defense-related organelles and structures

  • Monitor GAPC association with cellular membranes during pathogen attack

  • Correlate localization changes with defense activation

• Functional validation approaches:

  • Compare antibody staining between wild-type and GAPC-silenced plants

  • Research demonstrates that MeGAPCs-silenced cassava plants conferred improved disease resistance

  • Use antibodies to confirm silencing efficiency at the protein level

  • Apply antibodies in virus-induced gene silencing (VIGS) validation studies

What techniques can detect GAPC post-translational modifications during stress responses?

Post-translational modifications (PTMs) of GAPC can be detected using several specialized techniques:

• PTM-specific antibodies:

  • Use antibodies that specifically recognize phosphorylated, oxidized, or S-nitrosylated GAPC

  • Compare PTM status across different stress conditions

  • Examine spatial distribution of modified GAPC using immunofluorescence

  • Quantify the proportion of modified versus unmodified GAPC

• Mass spectrometry-based approaches:

  • Immunoprecipitate GAPC using antibodies and analyze by LC-MS/MS

  • Enrich for specific modifications (e.g., TiO₂ for phosphopeptides)

  • Perform quantitative proteomics to compare modification levels

  • Map specific modification sites on the GAPC sequence

• Biochemical separation methods:

  • Use 2D gel electrophoresis to separate GAPC isoforms based on charge and size

  • Detect with GAPC antibodies to identify modified forms

  • Compare modification patterns before and after stress treatment

  • Analyze how oxidative stress affects GAPC modifications

• Functional correlation studies:

  • Research indicates that oxidative stress inhibits the interaction of ATG3 with GAPCs

  • Examine how PTMs affect GAPC's interaction with autophagy proteins

  • Correlate PTM status with GAPC enzymatic activity

  • Investigate how modifications alter GAPC's role in immunity and stress responses

How can GAPC antibodies contribute to epitope-based vaccine development against bacterial pathogens?

GAPC antibodies play a crucial role in epitope-based vaccine development against bacterial pathogens:

• Epitope identification and validation:

  • Use monoclonal antibodies to screen phage-displayed peptide libraries

  • Research has identified epitopes like "TGFFAKK" (positions 97-103) and "TRINDLT" (positions 30-36) in S. dysgalactiae GapC

  • Verify epitopes through site-directed mutagenesis to identify critical residues

  • Studies show that residues G98, F99, F100, and K103 form the core of the "TGFFAKK" epitope

• Immunogenicity assessment:

  • Evaluate antibody responses to potential epitopes

  • Study shows that immunization with GapC₁₋₁₅₀ confers similar immunoprotection compared to full-length GapC

  • Measure antibody titers by ELISA following immunization

  • Assess cellular immunity markers (IL-4, interferon-γ, IL-17A)

• Protection evaluation:

  • Determine if antibodies neutralize bacterial virulence

  • Challenge studies in mice showed that immunization with GapC₁₋₁₅₀ provided protection against multiple Streptococcus species

  • Evaluate cross-protection against related bacterial strains

  • Analyze survival rates and bacterial burden in immunized subjects

• Vaccine formulation strategies:

  • Design peptide-carrier conjugates (e.g., keyhole limpet hemocyanin conjugates)

  • Create recombinant bacteria displaying GapC epitopes on their surface

  • Research has constructed an E. coli XL1-Blue strain (XL1-Blue/LOG76) that displays GapC₁₋₁₅₀ on its surface

  • Compare different delivery platforms for optimal immune responses

What methods can assess the role of GAPC in regulating autophagy?

The search results highlight GAPC's importance in autophagy regulation, with several methods available to investigate this relationship:

• Protein interaction analysis:

  • Use co-immunoprecipitation with GAPC antibodies to pull down autophagy proteins

  • Research demonstrates that MeGAPCs physically interact with autophagy-related proteins MeATG8b and MeATG8e

  • Similarly, cytoplasmic GAPDHs interact with ATG3 to negatively regulate autophagy

  • Examine how these interactions change during autophagy induction

• Autophagy activity measurement:

  • Monitor autophagic markers (LC3/ATG8 lipidation, p62/NBR1 degradation) in cells with normal or altered GAPC levels

  • Studies show that silencing of GAPCs significantly activates ATG3-dependent autophagy, while overexpression of GAPCs suppresses autophagy

  • Track autophagic flux using GFP-LC3 processing assays

  • Evaluate autophagosome formation using fluorescence microscopy

• Functional validation approaches:

  • Compare autophagy levels in GAPC-silenced versus control plants

  • Research shows that MeGAPCs inhibit autophagic activity

  • Examine how oxidative stress affects GAPC-mediated autophagy regulation

  • Studies indicate that oxidative stress inhibits the interaction of ATG3 with GAPCs

• Correlation with disease resistance:

  • Analyze how GAPC-regulated autophagy affects immunity

  • Research demonstrates that silencing of GAPCs enhances plant resistance against both incompatible pathogens (Tobacco mosaic virus and Pseudomonas syringae pv tomato DC3000) and compatible pathogen (P. syringae pv tabaci)

  • Examine autophagy markers in plants with different GAPC expression levels during pathogen challenge

  • Investigate how manipulating autophagy affects GAPC-mediated disease resistance

Why might GAPC antibodies show cross-reactivity with other proteins?

GAPC antibodies may exhibit cross-reactivity with other proteins for several reasons:

• Sequence conservation between GAPDH isoforms:

  • GAPDH is highly conserved across species and between isoforms

  • The cytosolic (GAPC) and plastidic forms share sequence similarity

  • Antibodies raised against one isoform may recognize conserved epitopes in others

  • Multiple GAPC genes exist in plants (e.g., cassava contains 6 cytosolic GAPDHs among 14 total GAPDH genes)

• Epitope similarities with unrelated proteins:

  • Some epitopes represent functional motifs shared across protein families

  • Linear epitopes may coincidentally match sequences in unrelated proteins

  • Conformational epitopes might be mimicked by different protein structures

  • Shorter epitopes have higher probability of occurring in multiple proteins

• Technical factors affecting specificity:

  • High antibody concentration can increase non-specific binding

  • Insufficient blocking or washing in immunoassays

  • Sample denaturation may expose normally hidden epitopes

  • Fixation methods can alter epitope structure and accessibility

• Validation strategies to address cross-reactivity:

  • Perform Western blot analysis on tissues from GAPC-silenced plants

  • Research demonstrates successful GAPC silencing through virus-induced gene silencing (VIGS)

  • Use peptide competition assays with the specific epitope

  • Compare results with multiple antibodies targeting different GAPC epitopes

How can I optimize immunohistochemistry protocols for GAPC localization studies?

Optimizing immunohistochemistry for GAPC localization requires attention to several key factors:

• Fixation optimization:

  • Compare different fixatives (paraformaldehyde, methanol, acetone)

  • Adjust fixation duration to maintain epitope accessibility

  • Consider epitope retrieval methods if necessary

  • Test mild fixation protocols to preserve protein-protein interactions

• Antibody selection and conditions:

  • Choose antibodies validated for immunohistochemistry applications

  • Determine optimal antibody concentration through titration

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use fluorescent secondary antibodies for better signal-to-noise ratio

• Sample preparation considerations:

  • Optimize section thickness for adequate signal penetration

  • Include permeabilization step for intracellular epitopes

  • Use appropriate blocking agents to reduce background

  • Consider tissue-specific autofluorescence quenching methods

• Controls and validation:

  • Include GAPC-silenced tissues as negative controls

  • Research shows successful GAPC silencing through virus-induced gene silencing

  • Perform peptide competition controls with immunizing peptide

  • Use co-localization with organelle markers to confirm subcellular distribution

  • Validate observations with alternative methods (e.g., GAPC-GFP fusion proteins)

What strategies can improve the detection sensitivity of low-abundance GAPC proteins?

Several approaches can enhance detection of low-abundance GAPC proteins:

• Signal amplification methods:

  • Tyramide signal amplification (TSA) for immunohistochemistry

  • Biotin-streptavidin systems for enhanced detection

  • Poly-HRP secondary antibodies for Western blot

  • Enhanced chemiluminescence (ECL) substrates with extended duration

• Sample enrichment techniques:

  • Immunoprecipitation to concentrate GAPC before analysis

  • Subcellular fractionation to isolate compartments with higher GAPC content

  • Protein precipitation methods to concentrate samples

  • Size exclusion to separate GAPC from abundant proteins

• Advanced detection technologies:

  • Automated capillary Western systems (Wes, Jess) with higher sensitivity

  • Multiplex fluorescent Western blotting

  • Digital ELISA platforms for single-molecule detection

  • Mass spectrometry with selected reaction monitoring (SRM)

• Experimental design considerations:

  • Use appropriate positive controls at known concentrations

  • Include standard curves for quantification

  • Optimize sample collection timing during peak expression

  • Consider using transient expression systems for method validation before examining endogenous proteins

How do I interpret conflicting results when comparing different GAPC antibodies?

Conflicting results with different GAPC antibodies require systematic analysis:

• Epitope-specific differences:

  • Different antibodies may target distinct epitopes on GAPC

  • Some epitopes might be masked in certain protein complexes

  • Post-translational modifications may affect epitope accessibility

  • The search results describe multiple epitopes like "TGFFAKK" and "TRINDLT" in GapC

• Systematic validation approach:

  • Characterize each antibody's epitope and binding properties

  • Test reactivity against recombinant GAPC and native samples

  • Verify antibody specificity using Western blot and ELISA

  • Examine recognition patterns in GAPC-silenced versus overexpression samples

• Methodological considerations:

  • Different fixation methods may affect epitope exposure in immunostaining

  • Sample preparation can impact antibody accessibility to epitopes

  • Buffer conditions may influence protein conformation

  • Some antibodies may work in certain applications but not others

• Interpretation framework:

  • Consider the possibility that different antibodies detect different GAPC subpopulations

  • Integrate results from multiple antibodies to build a comprehensive picture

  • Use orthogonal techniques (e.g., mass spectrometry) to validate findings

  • Weight results based on antibody validation quality and consistency with known biology

How might new antibody technologies enhance GAPC research?

Emerging antibody technologies offer significant potential for advancing GAPC research:

• Recombinant antibody engineering:

  • Single-chain variable fragments (scFvs) against specific GAPC epitopes

  • Nanobodies with enhanced tissue penetration for in vivo studies

  • Bi-specific antibodies to simultaneously target GAPC and interacting partners

  • Intracellular antibodies (intrabodies) for live-cell targeting of GAPC

• Spatiotemporal detection advancements:

  • Photoactivatable antibody conjugates for precise localization

  • Antibody-based biosensors for real-time monitoring of GAPC dynamics

  • Proximity labeling using antibody-enzyme fusions

  • Super-resolution microscopy compatible antibody labels

• High-throughput epitope mapping:

  • Phage display technology as described in the search results

  • Peptide microarrays for comprehensive epitope screening

  • In silico prediction combined with experimental validation

  • Deep mutational scanning to identify critical residues in epitopes

• Functional antibody applications:

  • Antibodies that selectively recognize specific GAPC conformational states

  • PTM-specific antibodies that detect oxidized or phosphorylated GAPC

  • Antibody-drug conjugates for targeted protein degradation

  • Cell-penetrating antibodies for live cell studies of GAPC function

What are promising research directions for GAPC antibodies in plant stress biology?

GAPC antibodies can enable several promising research directions in plant stress biology:

• Stress-induced GAPC relocalization studies:

  • Track GAPC movement between subcellular compartments during stress

  • Examine GAPC association with stress granules and processing bodies

  • Monitor potential nuclear translocation during specific stresses

  • Analyze GAPC redistribution during pathogen infection

• Investigating GAPC's role in stress-induced autophagy:

  • The search results show that GAPCs negatively regulate autophagy

  • Oxidative stress inhibits the interaction of ATG3 with GAPCs

  • Use antibodies to track how stress affects GAPC-ATG interactions

  • Correlate GAPC status with autophagosome formation during stress

• Exploring GAPC's role in ROS signaling networks:

  • Examine GAPC oxidation status using redox-specific antibodies

  • Research indicates that autophagy responds to reactive oxygen species (ROS)

  • Investigate how oxidative modifications affect GAPC's interactions and functions

  • Analyze GAPC in mutants with altered ROS production/scavenging

• GAPC interactome dynamics during stress adaptation:

  • Use GAPC antibodies for co-immunoprecipitation across stress conditions

  • Identify stress-specific GAPC interaction partners

  • Examine how stress duration affects GAPC complex formation

  • Compare GAPC interactomes in stress-tolerant versus sensitive genotypes

How can GAPC antibodies advance our understanding of cross-kingdom protein functions?

GAPC antibodies can provide valuable insights into cross-kingdom protein functions:

• Comparative analysis of GAPC structure-function relationships:

  • Use antibodies recognizing conserved epitopes across kingdoms

  • Compare subcellular localization patterns between plant, animal, and microbial GAPCs

  • Analyze kingdom-specific post-translational modifications

  • Investigate conserved versus divergent protein interactions

• Host-pathogen interaction studies:

  • Track how pathogen infection affects host GAPC distribution and function

  • Research shows MeGAPCs are negative regulators of plant disease resistance

  • Examine how bacterial GapC (a virulence factor) interacts with host systems

  • Investigate potential molecular mimicry between host and pathogen GAPCs

• Evolutionary conservation of GAPC regulation:

  • Compare GAPC involvement in autophagy across kingdoms

  • Research demonstrates that both plant GAPCs interact with autophagy proteins

  • Analyze conservation of regulatory mechanisms

  • Examine how different organisms use GAPC in stress responses

• Biotechnological applications:

  • Develop cross-reactive antibodies for comparative studies

  • Create antibodies that distinguish between host and pathogen GAPCs

  • Design tools to manipulate GAPC function across different organisms

  • Apply insights from multiple systems to engineer stress-resistant plants

What potential exists for GAPC antibodies in developing novel disease resistance strategies?

GAPC antibodies can contribute significantly to developing novel disease resistance strategies:

• Diagnostic applications:

  • Develop antibody-based sensors to detect GAPC changes during early infection

  • Monitor GAPC-regulated autophagy as an indicator of immune activation

  • Use changes in GAPC patterns to identify disease-resistant germplasm

  • Create high-throughput screening tools for resistance breeding programs

• Targeted modulation of GAPC function:

  • Design antibody-derived molecules to disrupt GAPC's negative regulation of immunity

  • Research shows that silencing of GAPCs enhances plant resistance against both incompatible and compatible pathogens

  • Develop tools to specifically block GAPC-ATG8 interactions

  • Create strategies to enhance GAPC-mediated defense signaling

• Epitope-based vaccine development:

  • Use research on B-cell epitopes of bacterial GapC for vaccine design

  • Studies show that GapC immunization confers cross-protection against multiple Streptococcus species

  • The amino acids 1-150 of GapC (GapC₁₋₁₅₀) confer similar immunoprotection as full-length GapC

  • Develop epitope vaccines targeting conserved regions identified by antibody research

• Genetic engineering strategies:

  • Use antibody-based screens to identify optimal GAPC variants for disease resistance

  • Design GAPC modifications that retain metabolic function while enhancing immunity

  • Create plants with inducible disruption of GAPC-ATG interactions during infection

  • Develop crops with enhanced autophagy regulation based on GAPC antibody research